has knowledgeable contact person
Protocols  >  Other protocol  >  EMEA guideline on Cell Base...

EMEA guideline on Cell Based Medicinal Products (CBMP)

Other protocol

BruCells has been actively involved in the discussion of the EMEA guideline on Cell Based Medicinal Products (CBMP). Catherine De Greef was present at the DC-THERA Cluster 4 Meeting in Bamberg (July 2007) where among other topics these guidelines were discussed and where the basis for a written statement has been worked out. During the finalisation of the statement, BruCells has mainly put forward the notion that the guidelines are not suitable to CBMP for the authorization of investigational trials, but are applicable in the procedure of obtaining market approval.

Protocol Steps:
EMEA guideline on Cell Based Medicinal Products (CBMP) Graph

created over 8 years ago (2 March 2009)    last modified over 5 years ago (28 May 2012)   [ RDF Rdf ]   [ RelFinder Relfinder ]